Alan Meeker

Medicine & Life Sciences

1. Telomere 100%
2. Prostatic Neoplasms 58%
3. Neoplasms 40%
4. Telomere Homeostasis 39%
5. Prostate 36%
6. Telomerase 35%
7. Telomere Shortening 27%
8. Micrococcal Nuclease 27%
9. Mutation 19%
10. Glioma 18%
11. Carcinogenesis 16%
12. Adenocarcinoma 15%
13. Fluorescence In Situ Hybridization 14%
14. Phenotype 13%
15. Stromal Cells 12%
16. Glioblastoma 12%
17. Tumor Microenvironment 12%
18. Prostatic Intraepithelial Neoplasia 12%
19. Androgen Receptors 11%
20. Neuroendocrine Tumors 11%
21. Breast Neoplasms 11%
22. Guanidine 10%
23. Carcinoma 10%
24. Breast 10%
25. Proteins 10%
26. Tumor-Infiltrating Lymphocytes 9%
27. Epithelial Cells 9%
28. Cellular Senescence 9%
29. Genomic Instability 8%
30. Chromosomal Instability 8%
31. DNA Damage 8%
32. Neoplasm Metastasis 7%
33. Biomarkers 7%
34. Immunohistochemistry 7%
35. Leukocytes 7%
36. Recurrence 7%
37. Stem Cells 7%
38. Astrocytoma 7%
39. human TERT protein 7%
40. DNA 7%
41. Ligands 6%
42. Genes 6%
43. Prostatectomy 6%
44. Gene Fusion 6%
45. Therapeutics 6%
46. telomerase RNA 6%
47. Epithelium 6%
48. Isocitrate Dehydrogenase 6%
49. Carcinoma in Situ 5%
50. Double-Stranded DNA Breaks 5%